When is it permitted to issue multiple CII prescriptions according to federal law?

The ability to issue multiple prescriptions for a controlled substance classified as a Schedule II (CII) medication is guided by specific federal regulations. When a prescriber intends for a patient to receive a CII medication over an extended treatment period, they can write multiple prescriptions that cover a total of up to a 90-day supply. This practice is permitted under federal law provided that:

1. Each prescription is written for a legitimate medical purpose.

2. The prescriptions are issued on the same day and include instructions indicating the date each should be filled.

3. The prescriber provides an explanation as to why the multiple prescriptions are necessary, ensuring that the patient’s health needs are addressed.

This allows patients to manage their medications more conveniently without the need for frequent doctor visits for refill prescriptions, particularly in cases where long-term treatment is necessary.

The other responses are either incorrect interpretations of the regulations or do not align with the availability and handling of CII medications under federal law. Federal legislation does not restrict the issuance of multiple CII prescriptions to a timeframe of 30 days or 60 days, nor is it contingent upon the patient being “registered.” Instead, it is essential that these prescriptions adhere to the stipulations mentioned above for them to be valid.